BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-15.32%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
(-18%)
Cap. Flow
-$28.8M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
99
New
8
Increased
29
Reduced
26
Closed
14
Top Buys
Top Sells
| 1 |
Assertio
ASRT
|
$25.1M |
| 2 |
ALR
Alere Inc
ALR
|
$23.9M |
| 3 |
Heron Therapeutics
HRTX
|
$13M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$9.47M |
| 5 |
Verastem
VSTM
|
$7.92M |
Sector Composition
| 1 | Healthcare | 90.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNCA
51
DELISTED
Genocea Biosciences, Inc.
GNCA
| $7.17M | 0.4% |
1,046,243
+49,483
| +5% | +$339K |
|
|
ANTH
52
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $7.03M | 0.39% |
1,154,674
-215,783
| -16% | -$1.31M |
|
|
VXRT
53
DELISTED
Vaxart
VXRT
| $6.9M | 0.38% |
3,486,711
+875,000
| +34% | +$1.73M |
|
|
PLXP
54
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $6.52M | 0.36% |
465,978
-9,022
| -2% | -$126K |
|
|
CFRX
55
DELISTED
ContraFect Corporation
CFRX
| $6.31M | 0.35% |
1,418,439
-1
| -0% | – |
|
56
Fate Therapeutics
FATE
$115M
| $5.94M | 0.33% |
1,113,986
-186,014
| -14% | -$992K |
|
57
Tenax Therapeutics
TENX
$27.5M
| $5.91M | 0.33% |
1,968,631
| – | – |
|
58
SCYNEXIS
SCYX
$35.2M
| $5.64M | 0.31% |
775,000
| – | – |
|
59
iRadimed
IRMD
$898M
| $5.61M | 0.31% |
230,358
-125,326
| -35% | -$3.05M |
|
|
BLRX
60
BioLineRX
BLRX
$15.5M
| $5.36M | 0.3% |
3,500,000
+400,000
| +13% | +$611K |
|
|
FLXN
61
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.8M | 0.27% |
323,188
-25,016
| -7% | -$372K |
|
62
Tonix Pharmaceuticals
TNXP
$243M
| $4.71M | 0.26% |
890,748
+130,000
| +17% | -$6.82M |
|
63
KalVista Pharmaceuticals
KALV
$713M
| $4.21M | 0.23% |
1,178,941
| – | – |
|
64
MediWound
MDWD
$180M
| $3.89M | 0.22% |
509,573
+389,705
| +325% | +$2.97M |
|
65
Accuray
ARAY
$165M
| $3.75M | 0.21% |
750,000
-250,000
| -25% | -$1.25M |
|
66
Veracyte
VCYT
$2.41B
| $3.45M | 0.19% |
736,196
| – | – |
|
|
EPRS
67
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $3.43M | 0.19% |
775,000
| – | – |
|
|
CASM
68
DELISTED
CAS Medical Systems, Inc.
CASM
| $3.27M | 0.18% |
2,618,296
| – | – |
|
69
OraSure Technologies
OSUR
$230M
| $3.04M | 0.17% |
685,528
| – | – |
|
|
WINT
70
DELISTED
Windtree Therapeutics Inc
WINT
| $2.85M | 0.16% |
9,489,166
+1,666,666
| +21% | +$500K |
|
|
CRDC
71
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $2.4M | 0.13% |
8,874,992
| – | – |
|
72
Phio Pharmaceuticals
PHIO
$11.9M
| $2.27M | 0.13% |
6,126,482
| – | – |
|
|
ALBO
73
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.27M | 0.13% |
5,155,530
-424,504
| -8% | -$187K |
|
74
Armata Pharmaceuticals
ARMP
$109M
| $2.18M | 0.12% |
+552,000
| New | +$2.18M |
|
75
Cidara Therapeutics
CDTX
$1.61B
| $2.12M | 0.12% |
166,875
+16,875
| +11% | +$215K |
|